SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-24-000125
Filing Date
2024-02-12
Accepted
2024-02-12 16:48:50
Documents
1
Group Members
ANTHONY A. FLORENCE, JRMOHAMAD H. MAKHZOUMINEA 13 GP, LTDNEA PARTNERS 10, LIMITED PARTNERSHIPNEA PARTNERS 13, L.P.NEW ENTERPRISE ASSOCIATES 13, L.P.SCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#2) nea10-glyco_18796.htm SC 13D/A 344820
  Complete submission text file 0001072613-24-000125.txt   346529
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Filed by) CIK: 0001132326 (see all company filings)

IRS No.: 061590878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87811 | Film No.: 24620811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)